Circulating procoagulant microparticles in acute pulmonary embolism: A case-control study

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 321-322

  Bal, Laurence ^a,b   Ederhy, Stéphane ^a,b   Di Angelantonio, Emanuele ^a,b   Toti, Florence ^c   Zobairi, Fatiha ^c   Dufaitre, Ghislaine ^a,b   Meuleman, Catherine ^a,b   Mallat, Ziad ^d   Boccara, Franck ^a,b   Tedgui, Alain ^d   Freyssinet, Jean Marie ^c   Cohen, Ariel ^a,b  

^a Saint Antoine University and Medical School   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c BICÊTRE HOSPITAL   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Acute pulmonary embolism; Circulating procoagulant microparticles; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; CALCIUM CHLORIDE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROTHROMBIN;

CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; LETTER; LUNG EMBOLISM; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; PRIORITY JOURNAL;

EID: 78650033899     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.11.048     Document Type: Article

References (11)

1. J.M. Freyssinet Cellular microparticles: what are they bad or good for? J Thromb Haemost 1 2003 1655 1662
2. Z. Mallat, H. Benamer, and B. Hugel Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes Circulation 101 2000 841 843
3. S. Ederhy, E. Di Angelantonio, and Z. Mallat Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation Am J Cardiol 100 2007 989 994
4. N. Inami, S. Nomura, and H. Kikuchi P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism Clin Appl Thromb Hemost 9 2003 309 316
5. J.A. Chirinos, G.A. Heresi, and H. Velasquez Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism J Am Coll Cardiol 45 2005 1467 1471
6. B. Hugel, F. Zobairi, and J.M. Freyssinet Measuring circulating-cell derived microparticles J Thromb Haemost 2 2004 1846 1847
7. A.D. Blann, and G.Y. Lip Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets Thromb Res 101 2001 321 327
8. M.E. Tesselaar, F.P. Romijn, and I.K. Van Der Linden Microparticle- associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 2007 520 527
9. W. Ageno, C. Becattini, and T. Brighton Cardiovascular risk factors and venous thromboembolism: a meta-analysis Circulation 117 2008 93 102
10. H.T. Sorensen, E. Horvath-Puho, and L. Pedersen Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study Lancet 370 2007 1773 1779
11. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150